Cell And Gene Therapy Videos

  1. Solvias Capabilities Update March 2026: Analytical Services 3/24/2026

    A biotech leader highlights end‑to‑end analytical capabilities from development to commercialization, with expertise in biologics, gene therapies, quality testing, and regulatory solutions.

  2. Catalent Capabilities Update March 2026: Analytical Services 3/24/2026

    A biologics analytics leader showcases development, testing, and characterization capabilities, emphasizing quality, regulatory compliance, and integrated support from discovery to commercialization.

  3. Minaris Advanced Therapies Capabilities Update March 2026: Cell & Gene Therapy 3/24/2026

    A global CDMO specializing in cell and gene therapies, offering end-to-end development, manufacturing, and testing services with over 25 years of expertise and personalized client support.

  4. Lonza Capabilities Update March 2026: Cell & Gene Therapy 3/24/2026

    A global CDMO outlines end-to-end capabilities in cell and gene therapy, mRNA, and microbial platforms, emphasizing scalability, innovation, and seamless development through commercial manufacturing.

  5. Landmark Bio Capabilities Update March 2026: Cell & Gene Therapy 3/24/2026

    A translational CDMO approach integrates development, analytics, and GMP manufacturing to streamline cell and gene therapy advancement from early research through scalable clinical production.

  6. Comprehensive Cell Solutions Capabilities Update March 2026: Cell & Gene Therapy 3/24/2026

    An integrated draw‑to‑thaw CDMO model connecting donor sourcing, development, GMP manufacturing, and cryogenic storage to streamline workflows, strengthen quality control, and speed clinical readiness.

  7. Evaluating Novel Whole Blood Preservation Methods As Alternatives To PBMC 3/22/2026

    Discover how alternative whole blood preservation methods can improve specimen stability, streamline global clinical trial logistics, and enhance immunophenotyping results.

  8. Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems 3/18/2026

    Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.

  9. Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery 3/17/2026

    Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.

  10. Minimizing Drug Product Loss In Manufacturing 3/17/2026

    Explore how optimized analytical testing, reduced material wastage, and advanced sterile fill-finish technologies can work together to preserve valuable GMP material without compromising quality.